News

Volpara announces Board of Directors Changes

Wellington, NZ, 15 January 2020: Volpara Health Technologies (“Volpara” or ”the Company”; ASX: VHT), a SaaS medical technology company whose AI imaging algorithms assist the early detection of breast cancer,...

Volpara Solutions Showcases End-to-End Cancer Screening Workflow at RSNA

Practice Management Tools Provide Access to Workflow and Image Quality Analytics to Help Improve Mammographic Quality and Maximize Resource Utilization. 

Volpara Solutions Applauds the DENSE Trial Results on Breast Cancer Screening

Randomized Controlled Trial Reduces Interval Breast Cancers in Women Assessed as Extremely Dense by Volpara®Density™ Software

Volpara Solutions Showcases AI-Powered Cancer Screening Platform at RSNA

Clinical Decision-Support Tools Provide Radiologists Easy Access to Key Insights to Offer Women a Personalized Breast Care Plan 

Volpara Solutions Announces Expansion of its Medical Advisory Board

Wellington, NZ, October 29, 2019: Volpara Solutions, an industry leader in cancer screening workflow, today announced the expansion of its global Medical Advisory Board.

Volpara Signs Distribution Agreement to Sell Transpara™, Screenpoint Medical’s AI Solution for Breast Cancer Detection

Wellington, NZ, July 23, 2019 – Volpara Solutions and ScreenPoint Medical BV today announced signature of an agreement under which Volpara will sell ScreenPoint’s Transpara™ products to breast imaging clinics...

Swedish Health Services Installs VolparaEnterprise Software to Enhance Mammography Image Quality

Breast Imaging Analytics Software Helps Breast Care Team Deliver Personalized Health with High-Quality Images

Volpara Health Technologies to Acquire MRS Systems, Inc.

Companies Committed to Deliver Technologies Enabling Personalized Breast Care

Journal of Breast Imaging Study Validates VolparaDensity in Tyrer-Cuzick Breast Cancer Risk Model

Wellington, NZ, May 20, 2019 – Research has demonstrated that the use of Volpara Solutions’ Volpara®Density™ software in combination with the Tyrer-Cuzick Breast Cancer Risk Evaluation Tool improves breast cancer...

Volpara Secures Medical Device Single Audit Program (MDSAP) 690110 Certification

MDSAP Certification Satisfies ISO and Regulatory Compliance Requirements for Japan, Australia, Canada, and the United States

1 2 3 4 5 7